Glutamate weighted imaging contrast in gliomas with 7 Tesla magnetic resonance imaging

INTRODUCTION: Diffuse gliomas are incurable malignancies, which undergo inevitable progression and are associated with seizure in 50–90% of cases. Glutamate has the potential to be an important glioma biomarker of survival and local epileptogenicity if it can be accurately quantified noninvasively....

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuroimage Clin
Autors principals: Neal, Andrew, Moffat, Bradford A., Stein, Joel M., Nanga, Ravi Prakash Reddy, Desmond, Patricia, Shinohara, Russell T., Hariharan, Hari, Glarin, Rebecca, Drummond, Katharine, Morokoff, Andrew, Kwan, Patrick, Reddy, Ravinder, O'Brien, Terence J., Davis, Kathryn A.
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2019
Matèries:
Regular Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6396013/
https://ncbi.nlm.nih.gov/pubmed/30822716
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nicl.2019.101694
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars